scispace - formally typeset
Journal ArticleDOI

Site-Directed Fragment-Based Screening for the Discovery of Protein-Protein Interaction Stabilizers.

Reads0
Chats0
TLDR
This first of its kind study illustrates the potential of the tethering approach to overcome the hurdles in systematic PPI stabilizer discovery by identifying orthosteric stabilizers that increase 14-3-3/ERα affinity up to 40-fold and proposing the mechanism of stabilization based on X-ray crystal structures.
Abstract
Modulation of protein–protein interactions (PPIs) by small molecules has emerged as a valuable approach in drug discovery. Compared to direct inhibition, PPI stabilization is vastly underexplored but has strong advantages, including the ability to gain selectivity by targeting an interface formed only upon association of proteins. Here, we present the application of a site-directed screening technique based on disulfide trapping (tethering) to select for fragments that enhance the affinity between protein partners. We target the phosphorylation-dependent interaction between the hub protein 14-3-3σ and a peptide derived from Estrogen Receptor α (ERα), an important breast cancer target that is negatively regulated by 14-3-3σ. We identify orthosteric stabilizers that increase 14-3-3/ERα affinity up to 40-fold and propose the mechanism of stabilization based on X-ray crystal structures. These fragments already display partial selectivity toward ERα-like motifs over other representative 14-3-3 clients. This fi...

read more

Citations
More filters
Journal ArticleDOI

Unifying principles of bifunctional, proximity-inducing small molecules

TL;DR: The chemical and biophysical principles common to all bifunctional, proximity-inducing small molecules are described and the underappreciated diversity of their chemical structures and biological mechanisms are discussed.
Journal ArticleDOI

Visualizing and trapping transient oligomers in amyloid assembly pathways.

TL;DR: Use of methods capable of detecting lowly-populated species within complex mixtures, such as NMR, single particle methods, and mass spectrometry, and chemical and biological tools to bias the amyloid energy landscape towards specific oligomeric states are discussed.
Journal ArticleDOI

Structure-Based Stabilization of Non-native Protein–Protein Interactions of Coronavirus Nucleocapsid Proteins in Antiviral Drug Design

TL;DR: 5-benzyloxygramine is identified as a new N protein PPI orthosteric stabilizer that exhibits both antiviral and N-NTD protein-stabilizing activities, and could be applied toward drug discovery against CoV diseases.
Journal ArticleDOI

Bifunctional chemical probes inducing protein-protein interactions.

TL;DR: This review highlights progress over the past three years on recruitment to E3 ubiquitin ligases by 'molecular glues' and chimeric dimerizers (PROTACs) for targeted protein degradation, and promises to significantly expand the range of tractable targets for chemical biology and therapeutic intervention.
References
More filters
Journal ArticleDOI

Reaching for high-hanging fruit in drug discovery at protein–protein interfaces

TL;DR: These studies discovered small molecules that bind with drug-like potencies to 'hotspots' on the contact surfaces involved in protein–protein interactions, and bind with much higher efficiencies than do the contact atoms of the natural protein partner.
Journal ArticleDOI

K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions

TL;DR: The development of small molecules that irreversibly bind to a common oncogenic mutant, K-Ras(G12C) and structure-based validation of a new allosteric regulatory site on Ras that is targetable in a mutant-specific manner are provided.
Journal ArticleDOI

Small-molecule inhibitors of protein-protein interactions: progressing toward the reality.

TL;DR: The past 20 years have seen many advances in understanding of protein-protein interactions (PPIs) and how to target them with small-molecule therapeutics; since then, potent inhibitors have been developed for diverse protein complexes, and compounds are now in clinical trials for six targets.
Journal ArticleDOI

Small molecules, big targets: drug discovery faces the protein–protein interaction challenge

TL;DR: The research leading to breakthroughs in PPI inhibition is described and the existence of groups of structurally related PPIs within the PPI target class is highlighted to illustrate the research strategies that have proved most useful.
Journal ArticleDOI

Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade

TL;DR: The molecular and structural basis of TTR tetramer stabilization by tafamidis is described, suggesting that binding stabilizes the weaker dimer-dimer interface against dissociation, the rate-limiting step of amyloidogenesis.
Related Papers (5)